Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Military briefing: Ukraine seeks way to break Russia’s Black Sea blockade
    • China cuts mortgage lending rate by record as lockdowns hit economy
    • EU blocks UK scientists from €95bn Horizon research programme
    • BoE chief economist warns on UK’s strong ‘inflationary momentum’
    • Italy imports more Russian oil to feed refineries
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Wall Street stocks sink into bear market as growth concerns mount
    • Sexual misconduct case rocks $47bn asset manager GoldenTree
    • Twitter deal leaves Elon Musk with no easy way out
    • How the Colombia election could change Latin America
    • Donald Trump risks coming up short in Georgia grudge match: ‘People are moving on’
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Sexual misconduct case rocks $47bn asset manager GoldenTree
    • THG rejects £2bn bid as Candy weighs up online retailer
    • Mercedes axes cheaper models in bid for luxury brand status
    • HSBC banker draws fire after accusing policymakers of climate change hyperbole
    • Why on earth did Warren Buffett swap Wells Fargo for Citigroup?
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Live news: Deere raises profit forecast as strong demand offsets supply chain constraints
    • Wall Street stocks sink into bear market as growth concerns mount
    • What are investors supposed to trust in now?
    • The Goldilocks crisis may have arrived for crypto
    • Live news updates from May 19: Over 8,000 civilians killed or injured in Ukraine war, THG rejects £2bn bid
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Why buying a flat might not be such a good idea
    • An abandoned subway is a tragedy for New York
    • There is a moral case against crypto
    • What are investors supposed to trust in now?
    • The Goldilocks crisis may have arrived for crypto
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • As a longtime trailing spouse, how do I get back into full-time work?
    • Are universities suffering from management bloat?
    • Spreadsheets are now cool, thanks to TikTok
    • “Oleg, it’s obviously great news that you have not been sanctioned”
    • Bonuses are outdated in the age of knowledge work
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Smart, co-operative, emotional: what cutting-edge science tells us about pigs
    • Why buying a flat might not be such a good idea
    • Ukraine’s ex-president Petro Poroshenko: ‘The army is like my child, and I am very proud’
    • What are investors supposed to trust in now?
    • The truckers who keep our world moving
  • How to Spend It
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Health Care

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 20 May, 2022
    Camilla Cavendish
    The NHS needs access to our shared medical data to save lives

    Public debate has been riddled with confusing claims, technical incompetence and vested interests

  • Wednesday, 18 May, 2022
    Coronavirus pandemic
    How can Covid-19 affect the human brain?

    Scientists are trying to understand the cause of neurological effects and whether symptoms will be long-lasting

  • Sunday, 1 May, 2022
    The Big Read
    Mental health and the pandemic: the growing crisis facing children

    Underfunding of some services and pent-up demand caused by lockdowns means some young people are waiting months for help

  • Thursday, 28 April, 2022
    Data PointsJohn Burn-Murdoch
    UK healthcare is already being privatised, but not in the way you think

    The creeping Americanisation of British medical bills reflects the strains on the NHS

  • Wednesday, 27 April, 2022
    Boots UK Ltd
    Apollo and Mukesh Ambani’s Reliance plan joint bid for Boots

    Private equity giant teams up with India’s largest company in attempt to buy UK pharmacy chain

  • Tuesday, 26 April, 2022
    Special Report
    FT Health: Innovation in Healthcare

    The final instalment of our series on innovation in European healthcare examines the effects of the slump in biotech valuations and changes in EU health policy

  • Tuesday, 26 April, 2022
    Special ReportFT Health: Innovation in Healthcare
    Pandemic bolsters EU’s role in health policy

    ‘There has been a change in attitudes. There are a lot of initiatives that were not foreseen a couple of years ago’

  • Tuesday, 26 April, 2022
    Special ReportFT Health: Innovation in Healthcare
    Streamlined EU process promises faster access to breakthrough drugs

    ‘Intricate dance’ under way to ensure simplified assessments of new medicines maintain quality and integrity

  • Saturday, 23 April, 2022
    Coronavirus treatment
    ‘Test to treat’ chaos is latest setback for US Covid pandemic response

    Biden’s flagship scheme giving antiviral pills to at-risk patients has run into multiple problems

  • Wednesday, 20 April, 2022
    LexRamsay Health Care Ltd
    Ramsay Health: KKR’s bid for sickly Aussie hospitals group is too low Premium content

    Minority shareholders should push for a higher price as earnings are ripe for recovery

  • Wednesday, 20 April, 2022
    KKR & Co LP
    KKR-led group launches $15bn bid for Australia’s biggest hospital company

    US private equity firm consortium makes leveraged buyout offer for Ramsay Health Care

  • Sunday, 17 April, 2022
    News in-depthNational Health Service
    Number of vacant NHS hospital beds falls to lowest level since start of pandemic

    Health service in England is grappling with twin challenges of Covid and clearing record treatment backlog

  • Wednesday, 13 April, 2022
    GlaxoSmithKline PLC
    GSK to buy Sierra Oncology for £1.5bn to boost cancer drug pipeline

    Sierra’s bone marrow cancer treatment had positive clinical trial results in January

  • Wednesday, 13 April, 2022
    Special ReportFT Health Centre
    FT Health: Future of Antibiotics

    The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain

  • Tuesday, 12 April, 2022
    Antibiotic resistance
    How will UK’s fixed-fee scheme for antibiotics help tackle the growing health crisis?

    Move could boost global development of drugs to ease antimicrobial resistance

  • Sunday, 10 April, 2022
    Rana Foroohar
    Pursuit of profit bodes ill for US healthcare

    Growing private equity investment in the health industry risks making the rich richer and the sick sicker

  • Wednesday, 6 April, 2022
    Coronavirus pandemic
    NHS trusts in England declare critical incident as hospital admissions near January high

    Ambulance and emergency care providers scale back services as cases of Omicron sub-variant continue to rise

  • Monday, 4 April, 2022
    Lex
    CareTech: public scrutiny of child services is driving take-private efforts Premium content

    Surprise approach for social care provider promises to relieve shareholders of stress

  • Monday, 4 April, 2022
    Cannabis industry
    Channel 4’s venture arm invests in cannabis company

    UK public service broadcaster swaps advertising slots for equity in medical marijuana group Cannaray

  • Sunday, 3 April, 2022
    Business should play a more active role in improving UK’s health, say researchers

    Responsibility for tackling conditions that affect life expectancy should not be left to government, study warns

  • Sunday, 3 April, 2022
    News in-depthNational Health Service
    Northumbria shows how new health levy can help reduce NHS waiting lists

    UK trust has improved outcomes with innovative practice and long-term planning

  • Wednesday, 30 March, 2022
    Health
    Poor care led to babies dying needlessly at UK hospital, inquiry finds

    12 mothers also died at Shrewsbury and Telford trust with many receiving treatment that ‘could have been significantly improved’

  • Tuesday, 29 March, 2022
    National Health Service
    Public satisfaction with the NHS falls to 25-year low across Britain

    Dissatisfaction rises during the pandemic driven by concerns over waiting times, staff shortages and lack of funding

  • Tuesday, 29 March, 2022
    Cleveland Clinic makes £1bn bet on London private healthcare

    Belgravia hospital aims to partner with the NHS to cut waiting lists and help with the UK’s post-Covid recovery plan

  • Friday, 25 March, 2022
    Private healthcare group NMC exits administration after two years

    UAE company collapsed after racking up $4bn of debts in an alleged fraud

Previous page You are on page 1 Next page

Topics related to Health & pharmaceuticals

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In